A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
Condition(s):Arteriosclerosis ObliteransLast Updated:March 10, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Arteriosclerosis ObliteransLast Updated:March 10, 2017Unknown status
Condition(s):Endovascular Repair of Aortic Aneurysm; Endovascular Treatment of Arteriosclerosis Obliterans of Lower ExtremitiesLast Updated:June 12, 2018Completed
Condition(s):Arteriosclerosis ObliteransLast Updated:November 17, 2022Completed
Condition(s):Arteriosclerosis ObliteransLast Updated:July 22, 2010Unknown status
Condition(s):Arteriosclerosis ObliteransLast Updated:April 28, 2011Completed
Condition(s):Type 2 Diabetes Mellitus; Arteriosclerosis ObliteransLast Updated:April 22, 2010Completed
Condition(s):Buerger Disease; Arteriosclerosis ObliteransLast Updated:December 30, 2005Unknown status
Condition(s):Foot Ulcers; Arteriosclerosis Obliterans; Diabetes MellitusLast Updated:January 4, 2017Completed
Condition(s):Diabetic Vascular Diseases; Arteriosclerosis Obliterans; Monckeberg Medial Calcific SclerosisLast Updated:June 4, 2018Unknown status
Condition(s):Arteriosclerosis; ExtremitiesLast Updated:October 9, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.